Change - Announcement of Cessation::RESIGNATION OF NON-EXECUTIVE NON-INDEPENDENT DIRECTOR

Issuer & Securities

Issuer/ Manager
BIOLIDICS LIMITED
Securities
BIOLIDICS LIMITED - SGXE89830751 - 8YY
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
11-Jan-2023 17:32:36
Status
New
Announcement Sub Title
RESIGNATION OF NON-EXECUTIVE NON-INDEPENDENT DIRECTOR
Announcement Reference
SG230111OTHRIVP0
Submitted By (Co./ Ind. Name)
Song Tang Yih
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Resignation of Mr Chen Johnson as the Non-Executive Non-Independent Director of Biolidics Limited (the "Company").

This announcement has been prepared by the Company and has been reviewed by the Company's sponsor, United Overseas Bank Limited (the "Sponsor"), for compliance with Rules 226(2)(b) and 753(2) of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST. The SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Lim Hoon Khiat, Director, Equity Capital Markets, who can be contacted at 80 Raffles Place, #03-03 UOB Plaza 1, Singapore 048624, telephone: +65 6533 9898.

Additional Details

Name Of Person
Chen Johnson
Age
50
Is effective date of cessation known?
Yes
If yes, please provide the date
01/02/2023
Detailed Reason (s) for cessation
Mr Chen Johnson has decided to resign as the Non-Executive Non-Independent Director of the Company to focus on his other work commitments.

Based on its enquiries, the Sponsor is satisfied that, save as disclosed in this announcement, there is no other material reason for the cessation of Mr Chen Johnson as the Non-Executive Non-Independent Director of the Company.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
19/07/2009
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
8
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Non-Executive Non-Independent Director and Founder, and Member of the Nominating Committee ("NC") of the Company.
Role and responsibilities
Responsibilities as the Non-Executive Non-Independent Director of the Company and a member of the NC.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
2,748,300 ordinary shares in the issued share capital of the Company
Other Directorships
Past (for the last 5 years)
1. Clearbridge Biophotonics Pte. Ltd.
2. Singapore Institute of Advanced Medicine Holdings Pte. Ltd.
3. DropCell Pte. Ltd.
4. Clearbridge BSA Pte. Ltd.
5. Clearbridge Assays Pte. Ltd.
6. Clearbridge Lifestyle Pte. Ltd.
7. Clearbridge Health (USA), Inc
8. Clearbridge Biophotonics, Inc
9. Clearbridge Biophotonics FPM, Inc
10. Asia HealthPartners Pte. Ltd.
11. Clearbridge Biomedics Japan Co., Limited
12. Inbridge Technologies Pte. Ltd. (Singapore)
Present
1. Clearbridge Health Limited
2. Inbridge Holdings Limited
3. 1Bridge Partners Limited
4. Hybrionic Pte. Ltd.
5. CapBridge CornerStone Pte. Ltd.
6. CapBridge Pte. Ltd.
7. Inbridge Ventures Pte. Ltd.
8. CapBridge Financial Pte. Ltd.
9. 1X Exchange Pte. Ltd.
10. CapBridge PSS Limited
11. CapBridge Hong Kong Limited
12. 1X Exchange PSS Limited
13. Ponte Capitis Pte. Ltd.